Visits to the emergency department were also lowered by 21%, and a modest decrease in stroke risk of 13% was also found
In the T2DM cohort, GSBR-1290 demonstrated a statistically significant reduction in HbA1c at week 12 (a decrease of -1.01% to -1.02%, placebo-adjusted)
However, adverse GI effects, particularly nausea, constipation, and dyspepsia, remain notable considerations
Pioglitazone therapy in progressive differentiated thyroid carcinoma
DNA dot-blots for 5-mC and 5-hmC revealed the patterns created by the events of the epigenetic modification enzymes
Researchers found a duration dependent link between the use of GLP-1s and the cumulative 3-year risk of major adverse cardiovascular events: myocardial infarction, stroke, or all-cause death